Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.

We aimed to evaluate perioperative outcomes in patients undergoing pancreaticoduodenectomy with or without a cardiac output goal directed therapy (GDT) algorithm. We conducted a multicentre randomised controlled trial in four high volume hepatobiliary-pancreatic surgery centres. We evaluated whether...

Full description

Bibliographic Details
Main Authors: Laurence Weinberg, Damian Ianno, Leonid Churilov, Ian Chao, Nick Scurrah, Clive Rachbuch, Jonathan Banting, Vijaragavan Muralidharan, David Story, Rinaldo Bellomo, Chris Christophi, Mehrdad Nikfarjam
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183313&type=printable
_version_ 1826579034444660736
author Laurence Weinberg
Damian Ianno
Leonid Churilov
Ian Chao
Nick Scurrah
Clive Rachbuch
Jonathan Banting
Vijaragavan Muralidharan
David Story
Rinaldo Bellomo
Chris Christophi
Mehrdad Nikfarjam
author_facet Laurence Weinberg
Damian Ianno
Leonid Churilov
Ian Chao
Nick Scurrah
Clive Rachbuch
Jonathan Banting
Vijaragavan Muralidharan
David Story
Rinaldo Bellomo
Chris Christophi
Mehrdad Nikfarjam
author_sort Laurence Weinberg
collection DOAJ
description We aimed to evaluate perioperative outcomes in patients undergoing pancreaticoduodenectomy with or without a cardiac output goal directed therapy (GDT) algorithm. We conducted a multicentre randomised controlled trial in four high volume hepatobiliary-pancreatic surgery centres. We evaluated whether the additional impact of a intraoperative fluid optimisation algorithm would influence the amount of fluid delivered, reduce fluid related complications, and improve length of hospital stay. Fifty-two consecutive adult patients were recruited. The median (IQR) duration of surgery was 8.6 hours (7.1:9.6) in the GDT group vs. 7.8 hours (6.8:9.0) in the usual care group (p = 0.2). Intraoperative fluid balance was 1005mL (475:1873) in the GDT group vs. 3300mL (2474:3874) in the usual care group (p<0.0001). Total volume of fluid administered intraoperatively was also lower in the GDT group: 2050mL (1313:2700) vs. 4088mL (3400:4525), p<0.0001 and vasoactive medications were used more frequently. There were no significant differences in proportions of patients experiencing overall complications (p = 0.179); however, fewer complications occurred in the GDT group: 44 vs. 92 (Incidence Rate Ratio: 0.41; 95%CI 0.24 to 0.69, p = 0.001). Median (IQR) length of hospital stay was 9.5 days (IQR: 7.0, 14.3) in the GDT vs. 12.5 days in the usual care group (IQR: 9.0, 22.3) for an Incidence Rate Ratio 0.64 (95% CI 0.48 to 0.85, p = 0.002). In conclusion, using a surgery-specific, patient-specific goal directed restrictive fluid therapy algorithm in this cohort of patients, can justify using enough fluid without causing oedema, yet as little fluid as possible without causing hypovolaemia i.e. "precision" fluid therapy. Our findings support the use of a perioperative haemodynamic optimization plan that prioritizes preservation of cardiac output and organ perfusion pressure by judicious use of fluid therapy, rational use of vasoactive drugs and timely application of inotropic drugs. They also suggest the need for further larger studies to confirm its findings.
first_indexed 2024-04-13T22:13:46Z
format Article
id doaj.art-d4d5d8f806e747809935f8ed90a07d26
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2025-03-14T14:11:52Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d4d5d8f806e747809935f8ed90a07d262025-02-27T05:36:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018331310.1371/journal.pone.0183313Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.Laurence WeinbergDamian IannoLeonid ChurilovIan ChaoNick ScurrahClive RachbuchJonathan BantingVijaragavan MuralidharanDavid StoryRinaldo BellomoChris ChristophiMehrdad NikfarjamWe aimed to evaluate perioperative outcomes in patients undergoing pancreaticoduodenectomy with or without a cardiac output goal directed therapy (GDT) algorithm. We conducted a multicentre randomised controlled trial in four high volume hepatobiliary-pancreatic surgery centres. We evaluated whether the additional impact of a intraoperative fluid optimisation algorithm would influence the amount of fluid delivered, reduce fluid related complications, and improve length of hospital stay. Fifty-two consecutive adult patients were recruited. The median (IQR) duration of surgery was 8.6 hours (7.1:9.6) in the GDT group vs. 7.8 hours (6.8:9.0) in the usual care group (p = 0.2). Intraoperative fluid balance was 1005mL (475:1873) in the GDT group vs. 3300mL (2474:3874) in the usual care group (p<0.0001). Total volume of fluid administered intraoperatively was also lower in the GDT group: 2050mL (1313:2700) vs. 4088mL (3400:4525), p<0.0001 and vasoactive medications were used more frequently. There were no significant differences in proportions of patients experiencing overall complications (p = 0.179); however, fewer complications occurred in the GDT group: 44 vs. 92 (Incidence Rate Ratio: 0.41; 95%CI 0.24 to 0.69, p = 0.001). Median (IQR) length of hospital stay was 9.5 days (IQR: 7.0, 14.3) in the GDT vs. 12.5 days in the usual care group (IQR: 9.0, 22.3) for an Incidence Rate Ratio 0.64 (95% CI 0.48 to 0.85, p = 0.002). In conclusion, using a surgery-specific, patient-specific goal directed restrictive fluid therapy algorithm in this cohort of patients, can justify using enough fluid without causing oedema, yet as little fluid as possible without causing hypovolaemia i.e. "precision" fluid therapy. Our findings support the use of a perioperative haemodynamic optimization plan that prioritizes preservation of cardiac output and organ perfusion pressure by judicious use of fluid therapy, rational use of vasoactive drugs and timely application of inotropic drugs. They also suggest the need for further larger studies to confirm its findings.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183313&type=printable
spellingShingle Laurence Weinberg
Damian Ianno
Leonid Churilov
Ian Chao
Nick Scurrah
Clive Rachbuch
Jonathan Banting
Vijaragavan Muralidharan
David Story
Rinaldo Bellomo
Chris Christophi
Mehrdad Nikfarjam
Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
PLoS ONE
title Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
title_full Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
title_fullStr Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
title_full_unstemmed Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
title_short Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
title_sort restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy a prospective multicentre randomized controlled trial
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183313&type=printable
work_keys_str_mv AT laurenceweinberg restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT damianianno restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT leonidchurilov restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT ianchao restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT nickscurrah restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT cliverachbuch restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT jonathanbanting restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT vijaragavanmuralidharan restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT davidstory restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT rinaldobellomo restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT chrischristophi restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial
AT mehrdadnikfarjam restrictiveintraoperativefluidoptimisationalgorithmimprovesoutcomesinpatientsundergoingpancreaticoduodenectomyaprospectivemulticentrerandomizedcontrolledtrial